Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.
Saved in:
| Title: | Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. |
|---|---|
| Authors: | Rizzello C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy., Sangaletti S; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Ratti C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Milani M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Via F. Chiesa 5, 6500, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Ente Ospedialiero Cantonale, Via A. Gallino 12, 6500, Bellinzona, Switzerland., Tripodo C; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy.; FIRC Institute of Molecular Oncology (IFOM), Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. claudia.chiodoni@istitutotumori.mi.it., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. mariopaolo.colombo@istitutotumori.mi.it. |
| Source: | Molecular cancer [Mol Cancer] 2022 Dec 12; Vol. 21 (1), pp. 215. Date of Electronic Publication: 2022 Dec 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36503430 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rizzello+C%22">Rizzello C</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Cancila+V%22">Cancila V</searchLink>; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Sangaletti+S%22">Sangaletti S</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Botti+L%22">Botti L</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ratti+C%22">Ratti C</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Milani+M%22">Milani M</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Dugo+M%22">Dugo M</searchLink>; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bertoni+F%22">Bertoni F</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Via F. Chiesa 5, 6500, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Ente Ospedialiero Cantonale, Via A. Gallino 12, 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tripodo+C%22">Tripodo C</searchLink>; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy.; FIRC Institute of Molecular Oncology (IFOM), Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Chiodoni+C%22">Chiodoni C</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. claudia.chiodoni@istitutotumori.mi.it.<br /><searchLink fieldCode="AU" term="%22Colombo+MP%22">Colombo MP</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. mariopaolo.colombo@istitutotumori.mi.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101147698%22">Molecular cancer</searchLink> [Mol Cancer] 2022 Dec 12; Vol. 21 (1), pp. 215. <i>Date of Electronic Publication: </i>2022 Dec 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147698 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4598 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214764598%22">14764598 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36503430 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12943-022-01687-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 215 Titles: – TitleFull: Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rizzello C – PersonEntity: Name: NameFull: Cancila V – PersonEntity: Name: NameFull: Sangaletti S – PersonEntity: Name: NameFull: Botti L – PersonEntity: Name: NameFull: Ratti C – PersonEntity: Name: NameFull: Milani M – PersonEntity: Name: NameFull: Dugo M – PersonEntity: Name: NameFull: Bertoni F – PersonEntity: Name: NameFull: Tripodo C – PersonEntity: Name: NameFull: Chiodoni C – PersonEntity: Name: NameFull: Colombo MP IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 12 Text: 2022 Dec 12 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1476-4598 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Molecular cancer Type: main |
| ResultId | 1 |